These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 15973722)
1. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Breen DP; Marinaki AM; Arenas M; Hayes PC Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722 [TBL] [Abstract][Full Text] [Related]
2. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304 [TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706 [TBL] [Abstract][Full Text] [Related]
4. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients. Kurzawski M; Dziewanowski K; Lener A; Drozdzik M Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528 [TBL] [Abstract][Full Text] [Related]
5. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine. Buster EH; van Vuuren HJ; Zondervan PE; Metselaar HJ; Tilanus HW; de Man RA Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):68-72. PubMed ID: 18090994 [TBL] [Abstract][Full Text] [Related]
6. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine. Zabala-Fernández W; Barreiro-de Acosta M; Echarri A; Carpio D; Lorenzo A; Castro J; Martínez-Ares D; Pereira S; Martin-Granizo I; Corton M; Carracedo A; Barros F J Gastrointestin Liver Dis; 2011 Sep; 20(3):247-53. PubMed ID: 21961091 [TBL] [Abstract][Full Text] [Related]
7. Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients. Xiong H; Xin HW; Wu XC; Li Q; Xiong L; Yu AR Fundam Clin Pharmacol; 2010 Jun; 24(3):393-400. PubMed ID: 19682085 [TBL] [Abstract][Full Text] [Related]
8. Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment. Uchiyama K; Nakamura M; Kubota T; Yamane T; Fujise K; Tajiri H J Gastroenterol; 2009; 44(3):197-203. PubMed ID: 19214663 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of thiopurine therapy in paediatric IBD patients. De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274 [TBL] [Abstract][Full Text] [Related]
10. Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. von Ahsen N; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Oellerich M; Kruis W; Reinshagen M; Schütz E Clin Chem; 2005 Dec; 51(12):2282-8. PubMed ID: 16214825 [TBL] [Abstract][Full Text] [Related]
11. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571 [TBL] [Abstract][Full Text] [Related]
12. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099 [TBL] [Abstract][Full Text] [Related]
13. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M; Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552 [TBL] [Abstract][Full Text] [Related]
14. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis. Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017 [TBL] [Abstract][Full Text] [Related]
15. Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases. Cheon JH; Kim JH; Kim BY; Kim SW; Hong SY; Eun CS; Hong SS; Byeon JS; Kim TI; Han DS; Yang SK; Lee KR; Kim WH Hepatogastroenterology; 2009; 56(90):421-3. PubMed ID: 19579612 [TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms. Lorenzoni PJ; Kay CSK; Zanlorenzi MF; Ducci RD; Werneck LC; Scola RH J Neurol Sci; 2020 May; 412():116734. PubMed ID: 32070863 [TBL] [Abstract][Full Text] [Related]
17. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients. Xin HW; Xiong H; Wu XC; Li Q; Xiong L; Yu AR Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245 [TBL] [Abstract][Full Text] [Related]
18. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment. Song DK; Zhao J; Zhang LR J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368 [TBL] [Abstract][Full Text] [Related]
19. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD). Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046 [TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Ansari A; Arenas M; Greenfield SM; Morris D; Lindsay J; Gilshenan K; Smith M; Lewis C; Marinaki A; Duley J; Sanderson J Aliment Pharmacol Ther; 2008 Oct; 28(8):973-83. PubMed ID: 18616518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]